Compare Nuvalent Inc (NUVL) vs Rocket Lab USA Inc (RKLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs Rocket Lab USA Inc — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Rocket Lab USA Inc trades at $73.95 (market cap $41.08B). The key difference: Rocket Lab USA Inc is far larger — about 4.2× Nuvalent Inc's market cap, and Nuvalent Inc is trading nearer its 52-week high, Rocket Lab USA Inc nearer its low. Which is the better fit depends on your goals.
| NUVL | RKLB | |
|---|---|---|
Market Cap | $9.81B | $41.08B |
Sector | Technology | Technology |
52-Week High | $123.96 | $150.23 |
52-Week Low | $72.16 | $39.48 |
Enterprise Value | $8.52B | $39.83B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About Rocket Lab USA Inc
Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →
